meeting point meeting point S everal presentations addressed the interaction between metabolic and inflammatory risk factors in the develop ment of obesity, type 2 diabetes and atherosclerosis. the immune system affects these processes at several levels, and inflammation in adipose tissue contributes to the development of insulin resistance. gwen randolph (Mount Sinai School of Medicine, New york, uSa) showed that dendritic cells that present antigens, and macrophages within the muscular wall of lymphatic collecting-vessels extend pseudo pods into the lumen of adipose lymphatic vessels. through these, they import lymph-derived antigens into adipose tissues in a ccL21/ccr7-dependent manner. in the absence of ccr7 expression, lymphderived antigens were not found in adipose dendritic cells or macrophages and inflammation was abated, suggesting that the lymphatic collecting-ducts communicate with the surrounding adipose tissue and macrophages to control the immune response. Jaap Neels (u. Nice, France) discussed the roles of the cXcL8-cXcr2 chemokinechemokine receptor system and paxillin/ α4-integrin interactions in monocyte/ macrophage rolling and arrest on adiposetissue endothelial vessel walls. He demonstrated their important role in the subsequent infiltration of adipose tissue by macrophages and the development of insulin resistance. He also highlighted the role of cD11c + cells in the induction of insulin resistance due to high-fat diets and in the expression of inflammatory markers.
Deficiency or inhibition of 5-lipoxy genasemediated leukotriene production altered the content of M1 and M2 in adipose tissue and protected against insulin resistance. Diane Mathis (Harvard Medical School, uSa) identified a subset of regu latory t cells (t rEg cells) in abdominal fat that express higher levels of pparγ1 than other t rEg cells. abdominal-fat t rEg cells produce high levels of iL-10, and their deletion leads to increased inflammation, obesity and insulin resistance on consumption of a high-fat diet. Luca Mazzarella (European institute of Oncology, Milan, italy) reported that high levels of insulin or insulin-like growth factor inhibit the induction of human FOXp3 + t rEg cells, which might lead to an increased inflammatory state.
Several other mechanisms were reported to be involved in inflammation in adipose tissue. the plasma concentration of cD40L is elevated in patients with type 2 diabetes and metabolic syndrome. Marjorie poggi (cardiovascular research institute, Maastricht, the Netherlands) reported that antibody-mediated depletion of cD40L improved metabolic control in a mouse model of a high-fat diet. Jean-François tanti (iNSErM u895, Nice, France) showed that macrophage-derived iL-1β and tumour necrosis factor (tNF) increase adipocyte expression of tpL2 (Map3K8). this controls cytokine-induced lipo lysis and downregulates insulin signalling. conversely, tpL2 inhibition in adipocyte-macrophage co-cultures reduces production of inflammatory cytokines.
anna Krook (Karolinska institutet, Sweden) discussed cytokine control of skeletal-muscle glucose metabolism. She showed that iL-6 and iL-13 are induced during exercise in muscle, inducing myotube formation, glycogen synthesis and glucose uptake in skeletal muscle cells. intriguingly, the skeletal muscle of type 2 diabetes patients is iL-6-resistant and secretes less iL-13, due to induction of the inhibiting microrNa 
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Wales, australia) compared insulin signalling in the monocytes of lean and obese individuals; the latter had decreased cellsurface gLut4 expression and related JNK, iKKβ and irS1-serine phosphorylation.
Several presentations addressed the regu lation of high-density lipoprotein (HDL) production, which is protective against cardio vascular disease. Laurent yvancharvet (columbia u., uSa) suggested an intriguing and novel regulatory role for aBca1 and aBcg1. these are well-known controllers of cholesterol efflux from macrophages. Both ABCA1 and ABCG1 genes are highly expressed on haematopoietic stem cells (HScs). the genetic deletion of these transporters in mice leads to proliferation of HScs, resulting in increased levels of circulating and infiltrating neutrophils, monocytes and eosinophils, with pro-atherogenic consequences. Eric Moses (texas Biomedical research institute, uSa) showed that variants of the gene coding for the pante theinase vanin 1, might determine plasma HDL cholesterol concentrations, and therefore atherogenesis. Laure perrin-cocon (iNSErM u851, Lyon, France) showed that HDL phospho lipids inhibit dendritic cell maturation and lipo polysaccharide (LpS)-induced NF-κB activity, identifying a novel immunomodulatory, and potentially anti-atherosclerotic, mechanism of HDL.
ziad Mallat (u. cambridge, uK) discussed the contribution of B lymphocytes to atherogenesis, and reported the beneficial effect of anti-cD20-mediated B-cell depletion. this led to decreased atherosclerosis, reduced interferon-γ levels and immunoglobulin g antioxidized low-density-lipoprotein (anti-oxLDL) antibody production, but enhanced iL-17. interestingly, cD20 depletion did not markedly influence anti-oxLDL immunoglobulin-M-producing B cells.
Kenneth rock (u. Massachusetts, uSa) discussed the induction of inflammation by sterile stimuli, such as urate and cholesterol crystals, through activation of the NrLp3 inflammasome that causes iL-1β maturation. phagocytosis of these crystals by macrophages triggers the inflammasome through lysosomal rupture and cathepsin-B activation-a mechanism that might contribute to the induction of athero sclerosis. Host sterol metabolism is essential for controlling viral replication. peter ghazal (u. Edinburgh, uK) presented data on the impact of virus-induced activation of pattern recognition receptors (prrs) on sterol metabolism, which suggests the existence of innate, immune-mediated cross-regulation of infection and sterol metabolism.
the pleiomorphism of the monocytemacrophage lineage and a precise definition of their activation statuses were also important topics of discussion. David Hume (u. Edinburgh, uK) performed geneexpression profiling in various monocyte populations to identify specific transcription networks. Surprisingly, many surface markers that were thought to be subpopulationspecific-such as cD11c, a dendritic-cell marker-are actually more specific for the inflammatory response than the cell subset. Extensive expression profiling of mouse and human cSF1-treated macrophages showed that 10% of genes are discordantly expressed and 25% showed significant differences in expression levels. Many gene pathways were found to be expressed differently in human and mouse macrophages, including the arginase and tryptophan metabolic pathways. graham thomas (u. Edinburgh, uK) studied modifications of gene-expression profiles in alternative (M2) macrophages induced by nematode infection. parasites mainly affected pathways involved in energy metabolism, in particular arachidonicacid metabolism, with a large increase in 5-and 15-lipoxygenase expression. Sophie Lotersztajn (Henri Mondor Hospital, créteil, France) discussed the protective role of the endocannabinoid receptor cBr2 in alcoholic liver disease. this receptor prevents alcohol-induced M1 polarization of Kupffer cells and supports transition into an M2 phenotype. réjane paumelle (iNSErM u1011, Lille, France) showed that deficiency in the anti-oncogene and cell-cycleregulator p16iNK4a polarizes macrophages from M1 to M2 in a manner independent of its cell-cycle-controlling activities. Liver Kupffer cells also belong to the monocyte/ macrophage lineage. ilse Scroyen (iNSErM u626, Marseille, France) presented data linking fatty liver disease and LpS-induced plasminogen activator inhibitor 1 (pai1) with its hypoglycaemic effect. Kupffer cells aggravate this process, possibly through the NF-κB pathway, although they are not primary actors.
christopher glass (u. california San Diego, uSa) reviewed the crucial positioning of nuclear receptors between metabolic and inflammatory pathways in his keynote address. He summarized the mechanisms of anti-inflammatory activity through trans-repression of pparγ, LXr and gluco corticoid receptor. trans-repression by LXrs and pparγ occurs through their SuMOylated forms, which inhibit the removal of the co-repressor Ncor from inflammatory-response gene promoters. recent findings have identified coronin 2a (cor2a) as an Ncor-complex protein. cor2a interacts with SuMO-LXr, and is thus a SuMO-LXr docking site. cor2a knockdown also resulted in decreased inflammatory-gene expression, and cor2a was found to be necessary for Ncor clearance from the promoter, by the recruitment of actin on LpS stimulation.
Bart Staels (iNSErM u1011, Lille, France) discussed the counter-intuitive presence of M2 macrophages in human atherosclerotic lesions. these macrophages have decreased cholesterol handling due to low LXrα expression. consequently, pparγ activation does not enhance aBca1 expression, but stimulates phagocytic activity by regulating thrombospondin 1 expression. antonio castrillo (iiBM cSic-uaM, Madrid, Spain) showed that LXr -/-mice lack marginal-zone macrophages, potentially due to differences in bone marrow progenitors in LXrα, but not LXrβ-null mice. as shown by andres Hidalgo (cNic, Madrid, Spain), the control of senescent neutrophil efferocytosis by macrophages enables LXrαβ to have an unexpected role in the regulation of circadian oscillations in haematopoietic stem and progenitor cell (HSpc) transport, which is negatively correlated with bone marrow cXcL12 levels. christine Delprat (cNrS uMr 5239, Lyon, France) showed that iL-17a promotes foam-cell formation by regulating lipid-metabolism genes as well as LXrα and pparγ in Langerhans cell histiocytosis. percy Knolle (u. Bonn, germany) identified a role for pparγ in experimental autoimmune encephalomyelitis (EaE). pparγ activation delays disease onset through its effects on cD4 + t lympho cytes. pparγ -/-cD4 + t cells are likely to develop into t H 17 cells, due to increased expression of the nuclear receptor rOrγt. Signals upstream from the gluco corticoid receptor also have a role in metabolic diseases linked to inflammation. Katia Karalis (children's Hospital, Harvard Medical School, uSa) showed that LpS treatment of corticotropin-releasing, hormone-deficient mice induces anorexia.
another theme of the meeting concerned the role of oxidative stress and the generation of reactive oxygen species (rOS) in the modulation of inflammatory responses. anna rubartelli (iSt, genova, italy) showed that rOS pro duction and subsequent activation of the antioxidant system are required for toll-like receptorinduced iL-1β secretion by myeloid cells. an improper redox response results in altered inflammasome activation and iL-1β secretion. Shyam Biswal (Johns Hopkins u., uSa) reported roles for nuclear factor erythroid 2-related factor (NrF2) and its inhibition by Kelch-like EcH-associated protein 1 in the expression of anti oxidant and de toxification enzymes. NrF2 in activation ameliorated athero sclerosis by leading to decreased activation of metabolic enzymes, decreased glucose uptake and oxidation, as well as decreased fatty-acid synthesis. By contrast, constitutive NFr2 activation in cancer cells enhanced metabolism and inflammation. alice carrier (iNSErM u624, Marseille, France) showed that rOS levels are controlled by tumour protein 53-induced nuclear protein 1, a target of p53 that is repressed by mir155 in cancer cells, further establishing a link between redox state, metabolism and cancer. Leonore Herzenberg (Stanford u., uSa) discussed the effect of N-acetylcysteine, an acetaminophen detoxifier, which increases growth-stimulating hormone levels in cystic fibrosis and HiV. She emphasized the beneficial effect of culturing cells under physiological conditions (5% O 2 ). Samuel rommelaere (ciML, Marseille, France) studied the complex action of epithelial vanin 1, a pantetheinase that provides tissue cysteamine. Vanin-1-deficiency aggravates type 1 diabetes, but protects animals from acute colitis and modulates resistance to infectious disease.
amino-acid catabolism is an ancestral survival strategy that controls immune responses in mammals. indoleamine 2,3-dioxygenase (iDO) catalyses the first step of tryptophan catabolism. ursula grohmann (u. perugia, italy) showed that iDO might have evolved in mammals to acquire signalling functions for the in duction and maintenance of long-term immune tolerance. in plasmacytoid dendritic cells, iDO signalling requires tgF-β-induced tyrosine phosphorylation of two immune tyrosine-based inhibitory motifs (itiMs) contained in the non-catalytic domain of the enzyme. as shown by andrea Nino castro (u. Bonn, germany), iDO is a key feature of regulatory denritic cells that exert micro bicidal activity in a model of chronic inflammation sustained by Listeria cells. the effect does not depend on tryptophan starvation, but is mediated by tryptophan metabolites. interestingly, human obesity is often associated with reduced plasma tryptophan and -/-and tOrc2 -/-mice, Jonathan powell (Johns Hopkins u., uSa) demonstrated that tOrc2 is involved in the control of weight and triglycerides, whereas tOrc1 drives organ-specific autoimmune and inflammatory diseases, such as experimental autoimmune encephalomyelitis. andy Johnson (u. pennsylvania, uSa) showed that activation of S6K, a kinase downstream from mtOr, is delayed in 'exhausted' cD8 + t cells responding to chronic viral infection, but is partly restored by ligation of the inhibitory receptor pD-1.
this meeting highlighted the increasingly complex, bidirectional interactions of immune cells and inflammation with metabolic alterations and cancer. Oxidative metabolism and nuclear receptors mechanistically link processes that were previously considered to be unconnected. the iDO-mtOr axis might represent a novel link between metabolic and immune/ inflammatory pathways. analyses of transcripts from particular immune subpopulations and cell-specific inactivation or overexpression of the proteins controlling these pathways should yield exciting discoveries in this emerging field.
